Russian journal of anaesthesiology and reanimatology 2, 2019 Клинические рекомендации фар

Intensive Care Med
. 2017;43(3):304-377.
139. Arulkumaran S, Karoshi M, Keith LG, Lalondé AB, Lynch CB (eds.). 
A Comprehensive Textbook of Postpartum Hemorrhage An Essential Clin-
ical Reference for Effective Management 2
nd
. The Global Library of Women’s 
Medicine—Sapiens Publishing
. 2012;654.
140. Dahlke J, Mendez-Figueroa H, Maggio L, Hauspurg A, et al. Prevention and 
management of postpartum hemorrhage: a comparison of 4 national guide-
lines. Am J Obstet Gynecol. 2015;213(1):76.e1-76.e10.
141. Haumonté J, Sentilhes L, Macé P, Cravello L, et al. Surgical treat-
ment of postpartum hemorrhage. J Gynecol Obstet Biol Reprod (Paris). 
2014;43(10):1083-1103.
142. Rani P, Begum J. Recent Advances in the Management of Major Postpar-
tum Haemorrhage — A Review. J Clin Diagn Res. 2017;11(2):QE01-QE05.
143. Henriquez D, Bloemenkamp K, van der Bom J. Management of postpar-
tum hemorrhage: how to improve maternal outcomes? J Thromb Haemost. 
2018. Available at: 
https://www.ncbi.nlm.nih.gov/pubmed/29883040.
144. Woods T, Scott K, Quick J. New Advances in the Care of the Hemorrhag-
ing Patient. Mo Med. 2018;115(5):434-437.
145. Working Party: Association of Anaesthetists of Great Britain & Ireland; Ob-
stetric Anaesthetists’ Association; Regional Anaesthesia UK. Regional an-
aesthesia and patients with abnormalities of coagulation: the Association of 
Anaesthetists of Great Britain & Ireland The Obstetric Anaesthetists’ Asso-
ciation Regional Anaesthesia UK. Anaesthesia. 2013;68(9):966-972.
146. Horlocker T, Vandermeuelen E, Kopp S, Gogarten W, et al. Region-
al Anesthesia in the Patient Receiving Antithrombotic or Thrombolyt-
ic Therapy: American Society of Regional Anesthesia and Pain Medi-
cine Evidence-Based Guidelines (Fourth Edition). Reg Anesth Pain Med. 
2018;43(3):263-309.
147. Delaney M, Wendel S, Bercovitz R, Cid J, et al. Biomedical Excellence for 
Safer Transfusion (BEST) Collaborative. Transfusion reactions: prevention, 
diagnosis, and treatment. Lancet. 2016;388(10061):2825-2836.
148. Osterman JL, Arora S. Blood Product Transfusions and Reactions. Hema-
tol Oncol Clin North Am
. 2017;31(6):1159-1170.
149. Friedman T, Javidroozi M, Lobel G, Shander A. Complications of Alloge-
neic Blood Product Administration, with Emphasis on Transfusion-Relat-
ed Acute Lung Injury and Transfusion-Associated Circulatory Overload. Adv 
Anesth
. 2017;35(1):159-173.
150. Wada H, Asakura H, Okamoto K, et al. Japanese Society of Thrombosis He-
mostasis/DIC Subcommittee: expert consensus for the treatment of DIC in 
Japan. Thromb Res. 2010;125(1):6-11.
151. Gando S, Saitoh D, Ogura H, et al. Japanese Association for Acute Med-
icine Disseminated Intravascular Coagulation (JAAM DIC) Study Group, 
Japanese Association for Acute Medicine Disseminated Intravascular Co-
agulation (JAAM DIC) Study Group. Natural history of disseminated in-
travascular coagulation diagnosed based on the newly established diagnos-
tic criteria for critically ill patients: results of a multicenter, prospective sur-
vey. Crit Care Med. 2008;36(1):145-150.
Клинические рекомендации ФАР 
FAR Clinical Recommendations